We just received data on a new analyst forecast for $JNJ. Tim Anderson from B of A Securities set a price target of 221.0 for JNJ.
To track analyst ratings and price targets for $JNJ, check out Quiver Quantitative's $JNJ forecast page.
Should you buy $JNJ?
Some analysts are better than others. To view the past performance of B of A Securities, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$JNJ Price Targets
Multiple analysts have issued price targets for $JNJ recently. We have seen 16 analysts offer price targets for $JNJ in the last 6 months, with a median target of $220.5.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $200.0 on 01/22/2026
- Louise Chen from Scotiabank set a target price of $265.0 on 01/22/2026
- Larry Biegelsen from Wells Fargo set a target price of $240.0 on 01/22/2026
- Rick Wise from Stifel set a target price of $220.0 on 01/22/2026
- Joshua Jennings from TD Cowen set a target price of $250.0 on 01/22/2026
- Tim Anderson from B of A Securities set a target price of $221.0 on 01/22/2026
- Lee Hambright from Bernstein set a target price of $208.0 on 01/09/2026
$JNJ Insider Trading Activity
$JNJ insiders have traded $JNJ stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:
- JOAQUIN DUATO (CEO and Chairman of the Board) sold 125,824 shares for an estimated $22,548,654
- JENNIFER L TAUBERT (EVP, WWC. Innovative Medicine) sold 56,471 shares for an estimated $10,040,882
- JOHN C REED (EVP, Innovative Medicine, R&D) sold 21,721 shares for an estimated $4,185,793
- JOSEPH J WOLK (Exec VP, CFO) sold 16,820 shares for an estimated $2,975,570
- JOHN G MORIKIS purchased 1,250 shares for an estimated $257,687
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$JNJ Revenue
$JNJ had revenues of $24.6B in Q4 2025. This is an increase of 9.08% from the same period in the prior year.
You can track JNJ financials on Quiver Quantitative's JNJ stock page.
$JNJ Congressional Stock Trading
Members of Congress have traded $JNJ stock 15 times in the past 6 months. Of those trades, 4 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 12/18, 11/13, 08/14.
- REPRESENTATIVE LLOYD DOGGETT purchased up to $15,000 on 12/09.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 11/20, 07/31.
- REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 10/30, 08/04 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 10/10.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
- REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 08/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$JNJ Hedge Fund Activity
We have seen 1,913 institutional investors add shares of $JNJ stock to their portfolio, and 1,923 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 12,124,049 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $2,248,041,165
- GQG PARTNERS LLC added 5,988,242 shares (+12137.4%) to their portfolio in Q3 2025, for an estimated $1,110,339,831
- GEODE CAPITAL MANAGEMENT, LLC removed 4,394,021 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $814,739,373
- BLACKROCK, INC. added 3,411,739 shares (+1.7%) to their portfolio in Q3 2025, for an estimated $632,604,645
- FLOSSBACH VON STORCH SE removed 3,347,823 shares (-52.8%) from their portfolio in Q3 2025, for an estimated $620,753,340
- CAPITAL INTERNATIONAL INVESTORS added 3,266,354 shares (+545.6%) to their portfolio in Q3 2025, for an estimated $605,647,358
- ASSENAGON ASSET MANAGEMENT S.A. removed 3,071,786 shares (-69.2%) from their portfolio in Q4 2025, for an estimated $635,706,112
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
